Showing 40,061 - 40,080 results of 135,496 for search '(( 2 c decrease ) OR ( 5 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 2.32s Refine Results
  1. 40061

    Table 1_Targeting nail psoriasis: IL-17A inhibitors demonstrate site-specific superiority over IL-23 inhibitor in a 24-week dermoscopy-guided real-world cohort.docx by Xiamei Yan (21014921)

    Published 2025
    “…</p>Results<p>(1) By week 24, PASI, BSA, DLQI and NAPSI scores had significantly decreased from baseline in all groups (P<0.001). (2) By week 24: SEC, IXE, and GUS groups saw nail matrix NAPSI score improvements of 65.9%, 60.5%, and 51.5%, with 68%, 55%, and 30% achieving NAPSI 60; Nail bed NAPSI score improvements were 58.8%, 68.6%, and 65.8%, with 28%, 65%, and 40% achieving NAPSI 60; Total NAPSI score improvements were 62.7%, 64.6%, and 53.7%, with 44%, 70%, and 30% achieving NAPSI 60. (3) All patients in the SEC and IXE groups achieved PASI 75, compared to 85% in the GUS group. …”
  2. 40062

    Image_5_Transcriptomic and Epigenomic Dynamics of Honey Bees in Response to Lethal Viral Infection.jpeg by Hongmei Li-Byarlay (5227208)

    Published 2020
    “…Israeli Acute Paralysis Virus (IAPV) is emerging as a model virus since its association with severe colony losses. …”
  3. 40063

    Table_5_Transcriptomic and Epigenomic Dynamics of Honey Bees in Response to Lethal Viral Infection.XLSX by Hongmei Li-Byarlay (5227208)

    Published 2020
    “…Israeli Acute Paralysis Virus (IAPV) is emerging as a model virus since its association with severe colony losses. …”
  4. 40064

    Tumor growth after tumor challenge in C57BL/6 mice immunized with recMAGE-A3 formulated with different immunostimulants. by Catherine Gérard (564552)

    Published 2014
    “…<p>The mice (n = 5) were immunized with recMAGE-A3 (10 µg of antigen) formulated with different immunostimulants and challenged with TC1-MAGE-A3 cells. …”
  5. 40065

    Data_Sheet_1_A Novel Third Wave Contextual Approach of Positive Behavior Support in School for Adolescent at High Psychosocial Risk: Rationale, Feasibility, and First Pilot Outcome... by Flavia Marino (8060402)

    Published 2019
    “…Third wave cognitive-behavioral interventions are increasingly becoming the chosen instruments to support psychological intervention for young people and adolescents. In this study, we aim to test the feasibility and the adequacy of the outcome measures of an intervention for adolescents at high psychosocial risk, using a modified Discoverer, Noticer, Advisor and Values (DNA-V) protocol aimed at increasing flexible and positive values. …”
  6. 40066

    Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor by Takeo Nakaya (423043)

    Published 2022
    “…Krüppel-like factor 5 (KLF5) is a potential target for anticancer drugs. …”
  7. 40067

    Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor by Takeo Nakaya (423043)

    Published 2022
    “…Krüppel-like factor 5 (KLF5) is a potential target for anticancer drugs. …”
  8. 40068

    Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor by Takeo Nakaya (423043)

    Published 2022
    “…Krüppel-like factor 5 (KLF5) is a potential target for anticancer drugs. …”
  9. 40069

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  10. 40070

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  11. 40071

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  12. 40072

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  13. 40073

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  14. 40074

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  15. 40075

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  16. 40076

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  17. 40077

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  18. 40078

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  19. 40079

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”
  20. 40080

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Here, we reported a novel compound corallorazine D from <i>Nocardiopsis</i> sp. …”